A citation-based method for searching scientific literature

L M Warner, L M Adams, S N Sehgal. Arthritis Rheum 1994
Times Cited: 127







List of co-cited articles
1231 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis.
Padmalatha S Reddy, Holly M Legault, Joseph P Sypek, Mark J Collins, Elizabeth Goad, Samuel J Goldman, Wei Liu, Stuart Murray, Andrew J Dorner, Margot O'Toole. Arthritis Res Ther 2008
29
27

Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway.
Weiping Cao, Santhakumar Manicassamy, Hua Tang, Sudhir Pai Kasturi, Ali Pirani, Niren Murthy, Bali Pulendran. Nat Immunol 2008
280
8

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
Joan T Merrill, C Michael Neuwelt, Daniel J Wallace, Joseph C Shanahan, Kevin M Latinis, James C Oates, Tammy O Utset, Caroline Gordon, David A Isenberg, Hsin-Ju Hsieh,[...]. Arthritis Rheum 2010
716
8


mTOR signaling in growth control and disease.
Mathieu Laplante, David M Sabatini. Cell 2012
8

Proliferation signal inhibitors in the treatment of lupus nephritis: preliminary experience.
Desmond Y H Yap, Maggie K M Ma, Colin So Tang, Tak Mao Chan. Nephrology (Carlton) 2012
29
27


Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.
Ramon G B Bonegio, Robert Fuhro, Zhiyong Wang, C Robert Valeri, Christopher Andry, David J Salant, Wilfred Lieberthal. J Am Soc Nephrol 2005
124
7

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.
D D Sarbassov, Siraj M Ali, Do-Hyung Kim, David A Guertin, Robert R Latek, Hediye Erdjument-Bromage, Paul Tempst, David M Sabatini. Curr Biol 2004
7

TOR signaling in growth and metabolism.
Stephan Wullschleger, Robbie Loewith, Michael N Hall. Cell 2006
7

A mammalian protein targeted by G1-arresting rapamycin-receptor complex.
E J Brown, M W Albers, T B Shin, K Ichikawa, C T Keith, W S Lane, S L Schreiber. Nature 1994
7


Impaired Fas response and autoimmunity in Pten+/- mice.
A Di Cristofano, P Kotsi, Y F Peng, C Cordon-Cardo, K B Elkon, P P Pandolfi. Science 1999
424
7

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.
Kirsten Neubert, Silke Meister, Katrin Moser, Florian Weisel, Damian Maseda, Kerstin Amann, Carsten Wiethe, Thomas H Winkler, Joachim R Kalden, Rudolf A Manz,[...]. Nat Med 2008
417
7

The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.
Yasemin Sancak, Timothy R Peterson, Yoav D Shaul, Robert A Lindquist, Carson C Thoreen, Liron Bar-Peled, David M Sabatini. Science 2008
7


Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
Ayumi Yoshizaki, Koichi Yanaba, Asako Yoshizaki, Yohei Iwata, Kazuhiro Komura, Fumihide Ogawa, Motoi Takenaka, Kazuhiro Shimizu, Yoshihide Asano, Minoru Hasegawa,[...]. Arthritis Rheum 2010
88
7


CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.
Tomohiro Koga, Christian M Hedrich, Masayuki Mizui, Nobuya Yoshida, Kotaro Otomo, Linda A Lieberman, Thomas Rauen, José C Crispín, George C Tsokos. J Clin Invest 2014
108
7

Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study.
G A W Bruyn, G Tate, F Caeiro, J Maldonado-Cocco, R Westhovens, H Tannenbaum, M Bell, O Forre, O Bjorneboe, P P Tak,[...]. Ann Rheum Dis 2008
56
12

Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.
Karen L Bride, Tiffaney Vincent, Kim Smith-Whitley, Michele P Lambert, Jack J Bleesing, Alix E Seif, Catherine S Manno, James Casper, Stephan A Grupp, David T Teachey. Blood 2016
93
7

Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.
Zachary Oaks, Thomas Winans, Nick Huang, Katalin Banki, Andras Perl. Curr Rheumatol Rep 2016
42
16


Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
Tak-Mao Chan, Kai-Chung Tse, Colin Siu-On Tang, Mo-Yin Mok, Fu-Keung Li. J Am Soc Nephrol 2005
310
6

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Ellen M Ginzler, Mary Anne Dooley, Cynthia Aranow, Mimi Y Kim, Jill Buyon, Joan T Merrill, Michelle Petri, Gary S Gilkeson, Daniel J Wallace, Michael H Weisman,[...]. N Engl J Med 2005
688
6


Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression.
K Banki, E Hutter, E Colombo, N J Gonchoroff, A Perl. J Biol Chem 1996
159
6


mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.
Do-Hyung Kim, D D Sarbassov, Siraj M Ali, Jessie E King, Robert R Latek, Hediye Erdjument-Bromage, Paul Tempst, David M Sabatini. Cell 2002
6

Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.
C J Sabers, M M Martin, G J Brunn, J M Williams, F J Dumont, G Wiederrecht, R T Abraham. J Biol Chem 1995
629
6

Upstream and downstream of mTOR.
Nissim Hay, Nahum Sonenberg. Genes Dev 2004
6

High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Maurits Demedts, Juergen Behr, Roland Buhl, Ulrich Costabel, Richard Dekhuijzen, Henk M Jansen, William MacNee, Michiel Thomeer, Benoit Wallaert, François Laurent,[...]. N Engl J Med 2005
639
6

Immune cells and cytokines in systemic lupus erythematosus: an update.
Vasileios C Kyttaris, Yuang-Taung Juang, George C Tsokos. Curr Opin Rheumatol 2005
67
8

High sirolimus levels may induce focal segmental glomerulosclerosis de novo.
Emmanuel Letavernier, Patrick Bruneval, Chantal Mandet, Jean-Paul Duong Van Huyen, Marie-Noëlle Péraldi, Imed Helal, Laure-Hélène Noël, Christophe Legendre. Clin J Am Soc Nephrol 2007
147
6

Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial.
Maria Dall'Era, Eliza Chakravarty, Daniel Wallace, Mark Genovese, Michael Weisman, Arthur Kavanaugh, Kenneth Kalunian, Patricia Dhar, Emmanuelle Vincent, Claudia Pena-Rossi,[...]. Arthritis Rheum 2007
218
6

Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
Madhusoodana P Nambiar, Carolyn U Fisher, Vishal G Warke, Sandeep Krishnan, Jeanne P Mitchell, Nancy Delaney, George C Tsokos. Arthritis Rheum 2003
79
7

Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity.
C Magistrelli, E Samoilova, R K Agarwal, K Banki, P Ferrante, A Vladutiu, P E Phillips, A Perl. Immunogenetics 1999
44
13

Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection.
Gyorgy Nagy, Jeffrey Ward, Dick D Mosser, Agnes Koncz, Peter Gergely, Christina Stancato, Yueming Qian, David Fernandez, Brian Niland, Craig E Grossman,[...]. J Biol Chem 2006
48
12



Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.
Emily C Baechler, Franak M Batliwalla, George Karypis, Patrick M Gaffney, Ward A Ortmann, Karl J Espe, Katherine B Shark, William J Grande, Karis M Hughes, Vivek Kapur,[...]. Proc Natl Acad Sci U S A 2003
6

mTOR: from growth signal integration to cancer, diabetes and ageing.
Roberto Zoncu, Alejo Efeyan, David M Sabatini. Nat Rev Mol Cell Biol 2011
6

Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways.
Sarah R Jacobs, Catherine E Herman, Nancie J Maciver, Jessica A Wofford, Heather L Wieman, Jeremy J Hammen, Jeffrey C Rathmell. J Immunol 2008
451
6

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León,[...]. Lancet 2011
985
6

Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.
Gabor G Illei, Yuko Shirota, Cheryl H Yarboro, Jimmy Daruwalla, Edward Tackey, Kazuki Takada, Thomas Fleisher, James E Balow, Peter E Lipsky. Arthritis Rheum 2010
320
6

Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population.
Xu-jie Zhou, Xiao-lan Lu, Ji-cheng Lv, Hai-zhen Yang, Lian-xiang Qin, Ming-hui Zhao, Yin Su, Zhan-guo Li, Hong Zhang. Ann Rheum Dis 2011
140
6



The role of IL-23/IL-17 axis in lupus nephritis.
Zheng Zhang, Vasileios C Kyttaris, George C Tsokos. J Immunol 2009
207
6

Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV.
Kunihiro Ichinose, Yuang-Taung Juang, José C Crispín, Katalin Kis-Toth, George C Tsokos. Arthritis Rheum 2011
60
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.